Welcome to the Investor Centre

Arix Bioscience plc (LSE: ARIX) is a global venture capital company focused on investing in breakthrough biotechnology companies around cutting edge advances in life sciences. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.

Our main goals are to make a difference to patients' lives and generate a return for our investors.

Latest Results Presentation

Highlights

£228m

NAV (at 30 June 2022)

176p

NAV per share (at 30 June 2022)

£131m

Cash (at 30 June 2022)

£93.9m

GPV (at 30 June 2022)

LON:ARIX